[FMS] Fresenius Medical Care Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization: 26.66 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 42.4 Change: 0.06 (0.14%)
Ext. hours: Change: 0 (0%)

chart FMS

Refresh chart

Strongest Trends Summary For FMS

FMS is in the long-term down -29% below S&P in 2 years and up 326% in 22 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) m

Fundamental Ratios
Shares Outstanding610.73 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y-20.08% Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow28.67 ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-237.29 M Cash From Investing Activities-208.84 M Cash From Operating Activities447.27 M Gross Profit1.18 B
Net Profit209.55 M Operating Profit504.4 M Total Assets25.11 B Total Current Assets6.6 B
Total Current Liabilities3.55 B Total Debt9.05 B Total Liabilities15.56 B Total Revenue3.96 B
Technical Data
High 52 week56.81 Low 52 week31.1 Last close37.95 Last change3.77%
RSI81.85 Average true range0.65 Beta0.61 Volume94.68 K
Simple moving average 20 days7.47% Simple moving average 50 days6.84% Simple moving average 200 days-16.13%
Performance Data
Performance Week5.98% Performance Month12.21% Performance Quart-4.12% Performance Half-24.08%
Performance Year-29.48% Performance Year-to-date17.17% Volatility daily1.48% Volatility weekly3.31%
Volatility monthly6.79% Volatility yearly23.51% Relative Volume258.11% Average Volume434.55 K
New High New Low

News

2019-06-07 17:11:08 | U.S. Renal Care, Inc New -- Moody's assigns a Caa2 rating to the senior unsecured notes of US Renal Care, Inc. NEW

2019-06-06 02:00:21 | INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?

2019-06-02 09:09:00 | Is Cara Therapeutics a Buy Now?

2019-05-30 12:28:07 | U.S. RENAL CARE, INC. NEW -- Moody's assigns a B3 CFR to US Renal Care, Inc. NEW; outlook stable

2019-05-30 07:48:11 | Cara Shares Up on Positive Phase III Data for Itchiness Drug

2019-05-29 13:00:00 | Fresenius Medical Care Breaks Ground on Knoxville Distribution Center

2019-05-23 13:52:08 | Fresenius Finance Ireland II Plc -- Moody's announces completion of a periodic review of ratings of Fresenius SE & Co. KGaA

2019-05-22 15:17:13 | Fresenius Medical Care US Finance II, Inc -- Moody's announces completion of a periodic review of ratings of Fresenius Medical Care Holdings, Inc.

2019-05-06 11:05:03 | Fresenius Medical FMS Q1 Earnings & Revenues Top Estimates

2019-05-02 15:24:26 | Edited Transcript of FME.DE earnings conference call or presentation 2-May-19 1:30pm GMT

2019-05-02 12:56:14 | Fresenius makes solid start to year after turbulent 2018

2019-04-18 14:57:10 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA  - FMS

2019-04-16 16:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

2019-04-12 13:40:45 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

2019-04-02 13:19:22 | Fresenius Medical Care to pay $231M to resolve bribery charges

2019-03-30 12:56:15 | Hedge Funds Have Never Been This Bullish On Fresenius Medical Care AG FMS?

2019-03-29 13:23:29 | Fresenius Medical Care to pay $231 mln to resolve criminal, civil foreign bribery charges

2019-03-29 12:53:47 | Fresenius Medical Care says U.S. settlement will not affect 2019, 2020 results

2019-03-29 12:43:00 | Fresenius Medical Care to pay $231 million to settle bribery charges

2019-03-26 11:48:03 | Fresenius Medical to Make Huge Investments, Competition Rife

2019-03-25 08:37:12 | Fresenius Medical's New Hemodialysis Software Gets FDA Nod

2019-03-19 10:41:02 | Baxter's BAX New Tie Up to Boost Acute Therapies Business

2019-03-15 13:40:37 | [$$] Fresenius Medical Care Readies for US Dialysis Shift

2019-03-14 10:05:02 | Should Value Investors Pick Fresenius Medical FMS Stock?

2019-03-11 09:49:30 | How Much Of Fresenius Medical Care AG & Co. KGaA ETR:FME Do Institutions Own?

2019-03-04 12:23:54 | U.S. seeks to cut dialysis costs with more home care versus clinics

2019-03-04 01:00:00 | FOCUS-U.S. seeks to cut dialysis costs with more home care versus clinics

2019-02-27 06:31:11 | Fresenius Medical FMS Earnings Beat, Revenues Miss in Q4

2019-02-26 07:00:00 | Fresenius Medical Care completes acquisition of NxStage Medical

2019-02-25 19:51:24 | [$$] German Dialysis Firm Reaches Agreement in Bribery Probe

2019-02-22 06:35:27 | FMC wraps up $2 bln acquisition of NxStage

2019-02-21 06:10:00 | Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2018

2019-02-20 21:42:18 | Edited Transcript of FME.DE earnings conference call or presentation 20-Feb-19 2:30pm GMT

2019-02-20 14:16:21 | Fresenius Medical Care AG & Co. FMS Q4 2018 Earnings Conference Call Transcript

2019-02-20 04:51:38 | FMC expects NxStage deal to close in next couple of days

2019-02-20 04:49:03 | Fresenius flags faster earnings growth from 2020 after investment

2019-02-20 04:38:47 | [$$] Fresenius Shares Rise on Strong Earnings

2019-02-20 01:24:24 | Fresenius Medical Care plans 1 bln eur share buyback

2019-02-19 08:35:44 | Should We Be Delighted With Fresenius Medical Care AG & Co. KGaA’s ETR:FME ROE Of 18%?

2019-01-31 16:09:56 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics

2019-01-30 08:31:48 | A Look At The Fair Value Of Fresenius Medical Care AG & Co. KGaA ETR:FME

2019-01-29 08:38:59 | FMC extends deadline for NxStage deal until Aug. 6 due to U.S. government shutdown

2019-01-24 14:56:46 | Becton, Dickinson Expected to Continue to Reward Shareholders

2019-01-22 07:08:00 | CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care

2019-01-16 08:14:01 | New Strong Sell Stocks for January 16th

2019-01-09 12:09:58 | Akorn Slides After Reporting FDA Warning Letter On Illinois Facility

2019-01-09 07:00:12 | New Strong Sell Stocks for January 9th

2019-01-08 07:21:12 | Baxter's PD Solution to Treat Patients, Prospects Bright

2019-01-03 17:43:10 | Cara CARA Up on IDMC's Recommendation to Continue Trial

2018-12-17 11:36:46 | Fresenius Medical Care AG & Co. FMS: Are Hedge Funds Right About This Stock?